Search Results - "Ozaki, R"

Refine Results
  1. 1

    Three-dimensional assessment of the normal Japanese glenoid and comparison with the normal French glenoid by Mizuno, N., Nonaka, S., Ozaki, R., Yoshida, M., Yoneda, M., Walch, G.

    “…In 2014, reverse total shoulder arthroplasty was approved in Japan. We were concerned that the base plate might be incompatible with Japanese who were…”
    Get full text
    Journal Article
  2. 2
  3. 3

    High risk of conversion to diabetes in first‐degree relatives of individuals with young‐onset type 2 diabetes: a 12‐year follow‐up analysis by Zhang, Y., Luk, A. O. Y., Chow, E., Ko, G. T. C., Chan, M. H. M., Ng, M., Kong, A. P. S., Ma, R. C. W., Ozaki, R., So, W. Y., Chow, C. C., Chan, J. C. N.

    Published in Diabetic medicine (01-12-2017)
    “…Aim Family history of diabetes is an established risk factor for Type 2 diabetes, but the impact of a family history of young‐onset diabetes (onset < 40 years)…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Non-linear relationship between birthweight and cardiometabolic risk factors in Chinese adolescents and adults by Tam, C. H. T., Wang, Y., Luan, J., Lee, H. M., Luk, A. O. Y., Tutino, G. E., Tong, P. C. Y., Ko, G. T. C., Ozaki, R., Tam, W. H., Kong, A. P. S., So, W. Y., Chan, J. C. N., Ma, R. C. W.

    Published in Diabetic medicine (01-02-2015)
    “…Aim To investigate the relationship between birthweight and cardiometabolic traits in two cohorts: one of Chinese adolescents and one of Chinese adults…”
    Get full text
    Journal Article
  8. 8

    Associations of uric acid and gamma-glutamyltransferase (GGT) with obesity and components of metabolic syndrome in children and adolescents by Kong, A. P. S., Choi, K. C., Ho, C. S., Chan, M. H. M., Ozaki, R., Chan, C. W. H., Chan, J. C. N.

    Published in Pediatric obesity (01-10-2013)
    “…Summary What is already known about this subject Associations between concentrations of uric acid and cardiovascular risk factors are known. The associations…”
    Get full text
    Journal Article
  9. 9
  10. 10

    P242 Accuracy of Doppler transabdominal ultrasound in assessing disease severity and extent in IBD by Sagami, S, Kobayashi, T, Kanazawa, T, Aihara, K, Morikubo, H, Ozaki, R, Okabayashi, S, Matsubayashi, M, Fuchigami, A, Kiyohara, H, Nakano, M, Hibi, T

    Published in Journal of Crohn's and colitis (25-01-2019)
    “…Abstract Background A paradigm shift in the treatment of inflammatory bowel disease (IBD) has emerged with recent medical advancements. Beyond clinical…”
    Get full text
    Journal Article
  11. 11

    The relationship between visceral adiposity and cardiometabolic risk in Chinese women with polycystic ovary syndrome by Ng, N.Y.H., Liu, K.H., Tam, C.H.T., Jiang, G., Cheng, F., Hou, Y., Yau, T.T., Ozaki, R., Chan, M.H., Lim, C.K., Sahota, D.S., Li, T.C., Cheung, L.P., Tam, W.H., Chu, W.C.W., Ma, R.C.W.

    Published in Obesity research & clinical practice (01-11-2021)
    “…To compare the extent to which visceral adiposity, as measured by mesenteric fat thickness, contribute to cardiometabolic risk, especially insulin resistance,…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Photonic crystals based on chiral liquid crystal by Ozaki, M., Matsuhisa, Y., Yoshida, H., Ozaki, R., Fujii, A.

    “…Liquid crystals including chiral molecule have a self‐organized helical structure with nano‐scaled periodicity, which can be regarded as a one‐dimensional (1D)…”
    Get full text
    Journal Article
  14. 14

    A simple risk score to identify Southern Chinese at high risk for diabetes by Ko, G., So, W., Tong, P., Ma, R., Kong, A., Ozaki, R., Chow, C., Cockram, C., Chan, J.

    Published in Diabetic medicine (01-06-2010)
    “…Diabet. Med. 27, 644–649 (2010) Aims  To develop a simple scoring system for identifying Southern Chinese at risk of diabetes. Methods  The score was derived…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    A randomized-controlled trial to investigate the effects of rivoglitazone, a novel PPAR gamma agonist on glucose-lipid control in type 2 diabetes by Kong, A. P. S., Yamasaki, A., Ozaki, R., Saito, H., Asami, T., Ohwada, S., Ko, G. T. C., Wong, C. K., Leung, G. T. C., Lee, K. F., Yeung, C. Y., Chan, J. C. N.

    Published in Diabetes, obesity & metabolism (01-09-2011)
    “…Aim: To examine the efficacy, safety and tolerability of rivoglitazone, a novel thiazolidinedione (TZD), and explore its effects on glucose and lipid control…”
    Get full text
    Journal Article